Projected Income Statement: Virbac

Forecast Balance Sheet: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -73.8 -79.4 -52.4 169 173 127 75.2 -41.2
Change - -7.59% 34.01% 422.52% 2.37% -26.5% -40.79% -154.79%
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR in Million
Estimates

Cash Flow Forecast: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 33.65 53.58 59.9 80.44 92.24 129.3 120.4 116.3
Change - 59.21% 11.8% 34.29% 14.67% 40.21% -6.93% -3.34%
Free Cash Flow (FCF) 1 96.25 45.41 58.74 123.8 106.8 84.66 120.6 150.2
Change - -52.82% 29.36% 110.73% -13.76% -20.7% 42.4% 24.6%
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Virbac

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 20.21% 18.37% 18.67% 20.25% 19.76% 20.32% 20.97% 21.52%
EBIT Margin (%) 15.87% 15.03% 14.83% 16.28% 15.68% 16.38% 16.84% 17.46%
EBT Margin (%) 14.95% 14.51% 13.97% 14.87% 14.85% 15.8% 16.71% 17.62%
Net margin (%) 10.64% 10.03% 9.73% 10.4% 10.3% 11.03% 11.51% 12.03%
FCF margin (%) 9.05% 3.73% 4.71% 8.86% 7.29% 5.46% 7.32% 8.66%
FCF / Net Income (%) 85.03% 37.22% 48.43% 85.2% 70.75% 49.48% 63.6% 72.04%

Profitability

        
ROA - 9.62% 8.7% 8.79% 8.02% 7.9% 7.8% 7.9%
ROE 16.82% 15.59% 13.94% 14.95% 13.92% 14.04% 13.41% 12.6%

Financial Health

        
Leverage (Debt/EBITDA) - - - 0.6x 0.6x 0.4x 0.22x -
Debt / Free cash flow - - - 1.36x 1.62x 1.5x 0.62x -

Capital Intensity

        
CAPEX / Current Assets (%) 3.16% 4.41% 4.8% 5.76% 6.3% 8.34% 7.31% 6.71%
CAPEX / EBITDA (%) 15.65% 23.99% 25.73% 28.42% 31.86% 41.03% 34.84% 31.18%
CAPEX / FCF (%) 34.96% 117.99% 101.98% 64.98% 86.4% 152.75% 99.83% 77.45%

Items per share

        
Cash flow per share 1 15.38 11.71 14.06 24.37 23.73 30.12 32.84 37.7
Change - -23.86% 20.09% 73.31% -2.61% 26.93% 9.01% 14.81%
Dividend per Share 1 1.25 1.32 1.32 1.45 1.45 1.724 2.04 2.38
Change - 5.6% 0% 9.85% 0% 18.88% 18.33% 16.68%
Book Value Per Share 1 85.82 99.42 107.6 124.6 134.3 152.4 172.5 194.3
Change - 15.85% 8.2% 15.79% 7.83% 13.47% 13.21% 12.61%
EPS 1 13.4 14.43 14.38 17.34 18 20.38 22.53 24.74
Change - 7.69% -0.35% 20.58% 3.81% 13.21% 10.58% 9.8%
Nbr of stocks (in thousands) 8,443 8,451 8,443 8,375 8,378 8,378 8,378 8,378
Announcement Date 3/22/22 A 3/23/23 A 3/19/24 A 3/13/25 A 3/17/26 A - - -
1EUR
Estimates
2026 *2027 *
P/E 16.6x 15x
PBR 2.21x 1.96x
EV / Sales 1.9x 1.76x
Yield 0.51% 0.6%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
337.50EUR
Average target price
411.88EUR
Spread / Average Target
+22.04%

Quarterly revenue - Rate of surprise